大麻使用障碍与后续精神病性及非精神病性单相抑郁和双相障碍风险
结果显示大麻使用障碍与单相抑郁及双相障碍风险升高相关,且与双相障碍精神病性亚型的关联强于非精神病性亚型。
要点
- 大麻使用障碍者单相抑郁风险升高(HR 1.84,95%CI 1.78-1.90)。
- 大麻使用障碍与双相障碍风险升高相关,精神病性双相风险更高(HR 4.05)。
- 大麻使用障碍对双相障碍精神病性亚型的关联强于非精神病性亚型。
核心结论
- 大麻使用障碍与精神病性和非精神病性双相障碍及单相抑郁风险升高相关。
- 这些发现可能为关于大麻使用法律地位和管控的政策提供参考。
研究设计与样本
- 前瞻性、基于人群的队列研究,使用丹麦全国登记数据。
- 采用Cox比例风险回归,暴露为登记诊断的大麻使用障碍,并调整性别、酒精使用障碍、物质使用障碍、出生地、日历年、父母教育水平、父母大麻/酒精/物质使用障碍及父母情感障碍。
主要发现
- 大麻使用障碍与单相抑郁风险升高相关(HR 1.84;95%CI 1.78-1.90)。
- 大麻使用障碍与精神病性单相抑郁(HR 1.97;95%CI 1.73-2.25)和非精神病性单相抑郁(HR 1.83;95%CI 1.77-1.89)风险升高相关。
- 大麻使用障碍与男性双相障碍(HR 2.96;95%CI 2.73-3.21)和女性双相障碍(HR 2.54;95%CI 2.31-2.80)风险升高相关。
- 大麻使用障碍与精神病性双相障碍(HR 4.05;95%CI 3.52-4.65)及男性非精神病性双相障碍(HR 2.96;95%CI 2.73-3.21)、女性非精神病性双相障碍(HR 2.60;95%CI 2.36-2.85)风险升高相关。
- 大麻使用障碍与双相障碍精神病性亚型的关联高于非精神病性亚型(相对HR 1.48;95%CI 1.21-1.81),但单相抑郁中无此差异(相对HR 1.08;95%CI 0.92-1.27)。
临床怎么用
- 在评估单相抑郁或双相障碍风险时,应将大麻使用障碍纳入病史采集与风险分层。
- 对合并大麻使用障碍的患者,需关注其精神病性亚型(尤其双相障碍)的更高风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Cannabis use is increasing worldwide and is suspected to be associated with increased risk of psychiatric disorders; however, the association with affective disorders has been insufficiently studied. OBJECTIVE: To examine whether cannabis use disorder (CUD) is associated with an increased risk of psychotic and nonpsychotic unipolar depression and bipolar disorder and to compare associations of CUD with psychotic and nonpsychotic subtypes of these diagnoses. DESIGN, SETTING, AND PARTICIPANTS: This prospective, population-based cohort study using Danish nationwide registers included all individuals born in Denmark before December 31, 2005, who were alive, aged at least 16 years, and living in Denmark between January 1, 1995, and December 31, 2021. EXPOSURE: Register-based diagnosis of CUD. MAIN OUTCOME AND MEASURES: The main outcome was register-based diagnosis of psychotic or nonpsychotic unipolar depression or bipolar disorder. Associations between CUD and subsequent affective disorders were estimated as hazard ratios (HRs) using Cox proportional hazards regression with time-varying information on CUD, adjusting for sex; alcohol use disorder; substance use disorder; having been born in Denmark; calendar year; parental educational level (highest attained); parental cannabis, alcohol, or substance use disorders; and parental affective disorders. RESULTS: A total of 6 651 765 individuals (50.3% female) were followed up for 119 526 786 person-years. Cannabis use disorder was associated with an increased risk of unipolar depression (HR, 1.84; 95% CI, 1.78-1.90), psychotic unipolar depression (HR, 1.97; 95% CI, 1.73-2.25), and nonpsychotic unipolar depression (HR, 1.83; 95% CI, 1.77-1.89). Cannabis use was associated with an increased risk of bipolar disorder in men (HR, 2.96; 95% CI, 2.73-3.21) and women (HR, 2.54; 95% CI, 2.31-2.80), psychotic bipolar disorder (HR, 4.05; 95% CI, 3.52-4.65), and nonpsychotic bipolar disorder in men (HR, 2.96; 95% CI, 2.73-3.21) and women (HR, 2.60; 95% CI, 2.36-2.85). Cannabis use disorder was associated with higher risk for psychotic than nonpsychotic subtypes of bipolar disorder (relative HR, 1.48; 95% CI, 1.21-1.81) but not unipolar depression (relative HR, 1.08; 95% CI, 0.92-1.27). CONCLUSIONS AND RELEVANCE: This population-based cohort study found that CUD was associated with an increased risk of psychotic and nonpsychotic bipolar disorder and unipolar depression. These findings may inform policies regarding the legal status and control of cannabis use.
引用
- Jefsen OH, Erlangsen A, Nordentoft M, et al. Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder. JAMA Psychiatry. 2023. PMID: 37223912. doi:10.1001/jamapsychiatry.2023.1256
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。